PR

Paritosh Rahi

Active Director Director DIN 10365466
DIN 10365466 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value •••• Premium profile

About Paritosh Rahi

Data last updated:

Paritosh Rahi is a Director at Healingways Lifesciences Private Limited (since 2023). The company operates in Pharma. Healingways Lifesciences Private Limited reported revenue of ₹8.3 Lakh (FY 2025).

DIN 10365466
Primary Designation Director
Industry Pharma
First Appointment 20 Oct 2023
Oldest Company Age 3 yrs
Largest company Healingways Lifesciences Private Limited · ₹8.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Oct 20232023₹8.3 Lakh (FY 2025)Active

Board colleagues of Paritosh Rahi

Directorship timeline

Open interactive timeline →
Healingways Lifesciences Private Limited
Premium access

Shareholding and investment profile for Paritosh Rahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paritosh Rahi

Paritosh Rahi currently holds 1 directorship: Healingways Lifesciences Private Limited (Director, since 20 Oct 2023, revenue ₹8.3 Lakh (FY 2025)).

Paritosh Rahi was first appointed on 20 Oct 2023 as Director at Healingways Lifesciences Private Limited.

The current boards of Paritosh Rahi's companies include Emmanual Lawrence (Healingways Lifesciences Private Limited), Mohit Kumawat (Healingways Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available